CD274 and neoplasm: The number of tumor-infiltrating lymphocytes, the expression level of programmed cell death-ligand 1 and tumor mutation burden and other indicators are higher than other subtypes of breast cancer, suggesting that TNBC has strong tumor microenvironment (TME) immune activity, which suggests that immunotherapy may be an effective treatment scheme.[3]